SCHEMBL15549649

SCHEMBL15549649

CCCCCCCC/C=C\CCCCCCCC(=O)C(N)[C@@H](N)C(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.57
CYP1A2 P05177 2/20 0.57
CYP2C19 P33261 2/20 0.57
KMT2A Q03164 2/20 0.57
SOAT1 P35610 2/20 0.57
MEN1 O00255 1/20 0.57
TP53 P04637 1/20 0.57
CYP3A4 P08684 1/20 0.57
TERT O14746 3/20 0.53
PTPN1 P18031 3/20 0.53
PPARG P37231 3/20 0.53
PPARD Q03181 3/20 0.53
PPARA Q07869 3/20 0.53
MAPT P10636 2/20 0.53
BLM P54132 2/20 0.53
HSD17B10 Q99714 2/20 0.53
FABP4 P15090 2/20 0.53
GMNN O75496 1/20 0.53
USP2 O75604 1/20 0.53
LMNA P02545 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2215864 0.86 FAAH (0.56) FAAHCYP1A2CYP2C19KMT2ASOAT1
SCHEMBL2218313 0.86 FAAH (0.56) FAAHCYP1A2CYP2C19KMT2ASOAT1
SCHEMBL29246353 0.86 FAAH (0.56) FAAHCYP1A2CYP2C19KMT2ASOAT1
SCHEMBL11330189 0.84 FAAH (0.61) FAAHCYP1A2CYP2C19KMT2ASOAT1
SCHEMBL25836769 0.83 FAAH (0.65) FAAHCYP1A2CYP2C19KMT2ASOAT1
SCHEMBL5507749 0.83 FAAH (0.65) FAAHCYP1A2CYP2C19KMT2ASOAT1
SCHEMBL16245390 0.83 FAAH (0.59) FAAHCYP1A2CYP2C19KMT2ASOAT1
SCHEMBL2216417 0.82 KDM4E (0.59) FAAHCYP1A2CYP2C19KMT2ASOAT1
SCHEMBL2048630 0.82 FAAH (0.67) FAAHCYP1A2CYP2C19KMT2ASOAT1
SCHEMBL2937979 0.82 FAAH (0.67) FAAHCYP1A2CYP2C19KMT2ASOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150202179-A1 FATTY ACID DERIVATIVES FOR USE IN A METHOD OF TREATING DEPRESSION AND ASSOCIATED CONDITIONS YISSUM RES DEV CO (IL) 2015-07-23 US claimed
US-20150202179-A1 FATTY ACID DERIVATIVES FOR USE IN A METHOD OF TREATING DEPRESSION AND ASSOCIATED CONDITIONS YISSUM RES DEV CO (IL) 2015-07-23 US disclosed
WO-2014013497-A1 FATTY ACID DERIVATIVES FOR USE IN A METHOD OF TREATING DEPRESSION AND ASSOCIATED CONDITIONS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2014-01-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150202179-A1 FATTY ACID DERIVATIVES FOR USE IN A METHOD OF TREATING DEPRESSION AND ASSOCIATED CONDITIONS ALOX5, FFAR2, FASN FAAH 10/4885CYP1A2 904/4885CYP2C19 477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.